Alaunos Therapeutics, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Alaunos Therapeutics, Inc. (TCRT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $85.50 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-14
- Alaunos Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-03-31 was $85.50.
- Alaunos Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-31 was $19.61, a 932.11% increase year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.90, a 48.37% decline year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $176.07, a 37.80% decline from fiscal 2024.
- Alaunos Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $283.09, a 59.94% increase from fiscal 2023.
- Alaunos Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $177.00, a 253.29% increase from fiscal 2022.
- Alaunos Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $50.10, a 1272.60% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $85.50 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | $85.50 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | $176.07 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $71.68 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | $68.63 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | $283.09 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | $283.08 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | $283.08 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | $19.61 10-Q · filed 2024-05-15 | ||||
| 2023-12-31 | $177.00 10-K · filed 2025-03-31 | $17.70 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $1.35 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $1.62 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $1.90 10-Q · filed 2023-05-10 | ||||
| 2022-12-31 | $50.10 10-K · filed 2024-04-01 | $3.34 10-K · filed 2023-03-07 | |||
| 2022-09-30 | $3.40 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $3.33 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | $3.68 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | $3.65 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $3.54 10-Q · filed 2021-11-08 | ||||
| 2021-06-30 | $3.86 10-Q · filed 2021-08-13 | ||||
| 2021-03-31 | $3.53 10-Q · filed 2021-05-06 | ||||
| 2020-12-31 | $4.22 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $3.84 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | $3.49 10-Q · filed 2020-08-06 | ||||
| 2020-03-31 | $4.67 10-Q · filed 2020-05-07 | ||||
| 2019-12-31 | $4.21 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | $4.11 10-Q · filed 2019-11-07 | ||||
| 2019-06-30 | $4.14 10-Q · filed 2019-08-08 | ||||
| 2019-03-31 | $4.33 10-Q · filed 2019-05-08 | ||||
| 2018-12-31 | $5.72 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $5.77 10-Q · filed 2018-11-09 | ||||
| 2018-06-30 | $5.50 10-Q · filed 2018-08-08 | ||||
| 2018-03-31 | $5.93 10-Q · filed 2018-05-10 | ||||
| 2017-12-31 | $6.64 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $6.64 10-Q · filed 2017-11-06 | ||||
| 2017-06-30 | $6.66 10-Q · filed 2017-07-31 | ||||
| 2017-03-31 | $6.25 10-Q · filed 2017-05-01 | ||||
| 2016-12-31 | $6.43 10-K · filed 2019-03-05 | ||||
| 2016-09-30 | $6.18 10-Q · filed 2016-11-09 | ||||
| 2016-06-30 | $6.48 10-Q · filed 2016-08-09 | ||||
| 2016-03-31 | $3.28 10-Q · filed 2016-05-10 | ||||
| 2015-12-31 | $4.36 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $4.13 10-Q · filed 2015-11-02 | ||||
| 2015-06-30 | $4.13 10-Q · filed 2015-08-10 | ||||
| 2015-03-31 | $4.26 10-Q · filed 2015-05-07 | ||||
| 2014-12-31 | $4.54 10-K · filed 2017-02-16 | ||||
| 2014-09-30 | $4.28 10-Q · filed 2014-10-30 | ||||
| 2014-06-30 | $5.05 10-Q · filed 2014-08-07 | ||||
| 2014-03-31 | $5.10 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | $4.58 10-K · filed 2016-02-24 | ||||
| 2013-09-30 | $4.57 10-Q · filed 2013-10-22 | ||||
| 2013-06-30 | $4.73 10-Q · filed 2013-08-08 | ||||
| 2013-03-31 | $4.88 10-Q · filed 2013-05-07 | ||||
| 2012-12-31 | $5.70 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $5.67 10-Q · filed 2012-11-08 | ||||
| 2012-06-30 | $5.90 10-Q/A · filed 2012-08-28 | ||||
| 2011-12-31 | $5.01 10-K · filed 2014-03-03 | ||||
| 2010-12-31 | $4.36 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |